⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BCRX News
BioCryst Pharmaceuticals Inc
BioCryst to Present New Data for ORLADEYO® (berotralstat) and Navenibart at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting
globenewswire.com
BCRX
BioCryst to Report Third Quarter 2026 Financial Results on November 4
globenewswire.com
BCRX
Atopic Dermatitis - Drug Pipeline Insight, 2026 | 100+ Companies and 120+ Therapies Fuel Biologics, TYK2 Inhibitors, Licensing, and Investment Opportunities
globenewswire.com
VNDA
APOG
BCRX
CELH
BioCryst Announces U.S. FDA Approval of ORLADEYO® 150 mg Oral Pellets for Adults and Adolescents with HAE
globenewswire.com
BCRX
Respiratory Infection Diagnostics Market Forecast 2025-2029 by Technology, Plex, Testing Site, Product, and Region | Multiplex and Point-of-Care Testing Unlock New Growth
globenewswire.com
QGEN
CODX
BDX
BIOX
TKO
GTEC
CUE
BFC
HOG
FGEN
ABT
DXCM
TMO
DHR
QDEL
LH
DGX
SYK
ALGN
EXAS
ILMN
GOOG
MSFT
AMZN
NVDA
INTC
AMD
CRM
IBM
ORCL
CSCO
NFLX
CMCSA
PEP
KO
MCD
DIS
BA
CAT
GE
XOM
CVX
PFE
MRK
JNJ
BMY
GILD
AMGN
REGN
VRTX
BIIB
AZN
SNY
NVS
TEVA
BABA
JD
BIDU
NTES
PDD
SIRI
EA
TTWO
ADPT
ALNY
ASMB
AXNX
BCRX
BEAM
CDXS
CGEN
CHKP
CLDX
CRIS
CTAS
CYTK
DAVA
DECK
DTIL
EDIT
ENTX
EVTC
EXEL
FATE
FCEL
FLEX
FORM
FTNT
FTV
GALT
GEN
GNTX
GRMN
GSK
HALO
HAYW
HBIO
HIMX
HOLX
HTHT
IDXX
INCY
INSM
INTU
IOVA
ISRG
JAZZ
KDP
KHC
KLAC
KODK
LAKE
LCID
LRCX
LSCC
LULU
LYFT
MCHP
MDLZ
MELI
MGM
MNST
MRVL
MU
NCLH
NDSN
NEO
NET
NI
NKE
NOC
NOV
NTAP
NXPI
OMC
ON
ORLY
OSK
OTIS
PACB
PAYX
PCAR
PCG
PENN
PERI
PETS
PGR
PHG
PI
PINS
PLAB
PLUG
PM
PNW
POOL
POST
PPG
PRGS
PRTA
PSX
PTC
PTON
PYPL
QCOM
QRVO
RCL
RDNT
REG
RGEN
RIVN
RL
ROST
RS
RVSN
RYAAY
S
SAN
SBAC
SBUX
SCHW
SE
SEDG
SEIC
SITE
SLAB
SLM
SMCI
SNA
SNOW
SNPS
SOFI
SPNS
SRPT
SSNC
STAG
STX
SWKS
T
TAL
TCOM
TDOC
TEAM
TECK
TER
TFX
TGT
TGS
TIGR
TLRY
TM
TMHC
TNDM
TNK
TOL
TOP
TOST
TPL
TRMB
TRMK
TRP
TSLA
TSN
TTD
TTC
TXN
TXRH
TYL
U
UAL
ULTA
UMC
UNH
UNP
UPS
URBN
V
VRSK
VRSN
VTR
VTRS
WDC
WEC
WEN
WFC
WGO
WHR
WMB
WMT
WST
WU
WYNN
XBIT
XCUR
XENE
XPO
XRAY
XYL
YETI
YUM
ZBRA
ZIM
ZION
ZTS
Peripheral T-Cell Lymphoma (PTCL) Market Insights, Epidemiology, and Forecast, 2026-2036 | 7MM Market to Double to $1.6 Billion as Targeted Therapies Drive 7% CAGR
globenewswire.com
PFE
TSEM
CRSP
BCRX
MRK
BMY
GLP-1 Drugs Market to Reach USD 132.79 Billion by 2035 as Oral Therapies, Tirzepatide and Obesity Applications Reshape Competition
globenewswire.com
NVO
LLY
BCRX
BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth
globenewswire.com
BCRX
Callio Therapeutics Appoints Chris Hassig, PhD, as Chief Scientific Officer
globenewswire.com
BCRX
Peer AI Expands Submission Risk Prediction with Live Agency Monitoring
prnewswire.com
BIIB
TAK
BCRX